BCL2 and neoplasm: Immunohistochemistry results showed positivity for TLE1, EMA, BCL-2, CKH, CK18, and Kiel-67 (in 46% of cells) in some regions of tumor cells; and negativity for Desmin, CD34, S-100, and CD117 in tumor cells.